Form 4: Generation Bio Director's Stock Transactions Post-CEO Exit
Insider Transaction Report
Generation Bio Director Geoff McDonough reported stock transactions including RSU vesting acceleration and common stock acquisition and disposition following his resignation as CEO.
Summary
- Geoff McDonough, a Director at Generation Bio Co. (GBIO), reported changes in his beneficial ownership on October 31, 2025.
- 659 restricted stock units (RSUs) vested and converted into common stock, an acceleration triggered by his resignation as the Issuer's Chief Executive Officer & President.
- Concurrently, 293 shares of common stock were disposed of at a price of $5.51 per share, likely for tax withholding purposes.
- Following these transactions, McDonough directly owns 137,202 shares of common stock and indirectly owns 22,646 shares via the McDonough Family 2018 Irrevocable Trust and 27,500 shares via the McDonough Family 2020 Irrevocable Trust.
- He also beneficially owns 1,977 restricted stock units directly.
Sentiment
Score: 5
Explanation: The filing reports routine insider stock transactions (vesting and disposition for tax) for a director. The acceleration of vesting is due to the reporting person's resignation as CEO & President, which is a notable management change, but the filing itself is a disclosure of the transaction rather than a performance update.
Positives
- Vesting of 659 restricted stock units, increasing direct common stock holdings.
Negatives
- Disposition of 293 common shares at $5.51 per share, likely for tax purposes, reducing direct holdings.
- The acceleration of vesting was due to Geoff McDonough's resignation as the Issuer's Chief Executive Officer & President, indicating a significant management change.
Future Outlook
NA
Industry Context
NA
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Executive Officer & President | Geoff McDonough | Not specified in this filing | Prior to October 31, 2025 (implied by accelerated vesting) | Resignation |
Related Party Transactions
- Indirect beneficial ownership of 22,646 shares of common stock through the McDonough Family 2018 Irrevocable Trust, where the reporting person is the settlor.
- Indirect beneficial ownership of 27,500 shares of common stock through the McDonough Family 2020 Irrevocable Trust, where the reporting person is the settlor.
Stakeholder Impact
- Shareholders are informed of changes in a director's beneficial ownership and the underlying reason of a CEO and President resignation, which can influence perceptions of leadership stability.
Key Dates
| Date | Description |
|---|---|
| 2022-07-15 | Initial vesting date for 25% of the shares underlying the restricted stock units granted on January 20, 2023. |
| 2023-01-20 | Grant date of 8,437 restricted stock units to Geoff McDonough. |
| 2025-10-31 | Transaction date for RSU vesting, common stock acquisition, and common stock disposition. |
| 2025-11-21 | Signature date of the reporting person's attorney-in-fact on the filing. |
Keywords
Generation Bio, GBIO, Form 4, Insider Trading, Stock Transactions, Restricted Stock Units, CEO Resignation, Director Stock Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.